TNDM - タンデム・ダイアベティス・ケア (Tandem Diabetes Care Inc.)

TNDMのニュース

   Tandem Diabetes Care (NASDAQ:TNDM) Price Target Raised to $140.00  2021/11/07 12:08:41 Dakota Financial News
Tandem Diabetes Care (NASDAQ:TNDM) had its price target hoisted by Piper Sandler from $132.00 to $140.00 in a research report released on Thursday, The Fly reports. Piper Sandler currently has an overweight rating on the medical device companys stock. Piper Sandler also issued estimates for Tandem Diabetes Cares Q4 2021 earnings at $0.17 EPS, FY2021 []
   Tandem Diabetes Care (NASDAQ:TNDM) Announces Earnings Results, Beats Estimates By $0.01 EPS  2021/11/06 17:04:41 Dakota Financial News
Tandem Diabetes Care (NASDAQ:TNDM) issued its quarterly earnings data on Wednesday. The medical device company reported $0.09 earnings per share (EPS) for the quarter, beating the Zacks consensus estimate of $0.08 by $0.01, MarketWatch Earnings reports. Tandem Diabetes Care had a net margin of 1.08% and a return on equity of 3.68%. During the same []
   Piper Sandler Increases Tandem Diabetes Care (NASDAQ:TNDM) Price Target to $140.00  2021/11/06 15:28:42 Dakota Financial News
Tandem Diabetes Care (NASDAQ:TNDM) had its target price boosted by equities research analysts at Piper Sandler from $132.00 to $140.00 in a report released on Thursday, The Fly reports. The firm currently has an overweight rating on the medical device companys stock. Piper Sandlers target price would indicate a potential upside of 7.16% from the []
   Steward Partners Investment Advisory LLC Sells 300 Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM)  2021/11/06 09:10:41 Transcript Daily
Steward Partners Investment Advisory LLC trimmed its position in shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM) by 41.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 420 shares of the medical device company’s stock after selling 300 shares […]
   Tandem Diabetes Care Inc (TNDM) EVP & CHIEF FINANCIAL OFFICER Leigh Vosseller Sold $1. ...  2021/11/05 23:15:02 GuruFocus
Related Stocks: TNDM ,
   Artificial Pancreas Devices Systems Market 2021: Detailed Analysis of Current Industry Figures with Forecasts Growth By 2028| Medtronic, Bigfoot Biomedical, Beta Bionics, Admetsys, Insulet, Tandem Diabetes Care, Defymed, and Others.  2021/09/01 10:27:44 OpenPR
The global artificial pancreas device systems market exhibited strong growth during 2015-2021. Looking forward, IMARC Group expects the market to grow at a CAGR of 12% during 2021-2028. Artificial pancreas device system are the devices that closely copy the glucose regulating function
   Digital Diabetes Device Market Size 2021 by Product Sales, Revenue, Price, Market Share, Growth Opportunity and Forecast to 2027 Research Report I Top key players-Lifescan, Roche, Medtronic, Ascensia Diabetes Care, TANDEM Diabetes Care, DEXCOM, Social D  2021/08/30 11:15:37 OpenPR
Digital diabetes devices are the executives'' arrangements are cell phone associated diabetes the board gadgets and programming stages utilized by patients experiencing Type 1, Type 2, and gestational diabetes. Clinical experts likewise utilize these answers to oversee diabetes. Get sample copy
   Beyond Type 1 Named an Official Charity Partner of the 2021 TCS New York City Marathon  2021/08/25 19:00:00 Benzinga
SAN CARLOS, Calif., Aug. 25, 2021 /PRNewswire/ -- Global diabetes nonprofit Beyond Type 1 was named an Official Charity Partner for the 2021 TCS New York City Marathon, taking place on November 7 . This year serves as the 50th celebratory running of the marathon. Beyond Type 1 will be among the more than 400 official charity partners providing thousands of runners the opportunity to run in the world''s most popular marathon. Presented by Dexcom and Tandem Diabetes Care , this year''s Beyond Type Run Team is made up of 50 runners living with Type 1 diabetes (T1D) from 23 states and five countries. These individuals are raising awareness and funds for Type 1 diabetes as ambassadors for Beyond Type 1, showcasing how they live beyond their diagnoses and supporting crucial efforts and programs for others affected by this condition. "We''re thrilled to get the chance to assemble another incredible and inspiring team showing people with diabetes everywhere that anything is possible with this condition," said Beyond Type 1 CEO Thom Scher . "We''re grateful for support from Dexcom and Tandem Diabetes Care and the opportunity to connect and inspire community members through Beyond Type Run." Beyond Type 1 has taken three prior teams to the TCS New York City Marathon in 2017, 2018 and 2019 with a goal of inspiring individuals affected by diabetes all over the world.
   Consonance Capital Management LP Buys Tandem Diabetes Care Inc, Globus Medical Inc, Protagonist ...  2021/08/18 16:38:17 GuruFocus
Related Stocks: GMED , PTGX , LEGN , VSTM , TNDM , SRPT , CHFW.U , SLN , JYAC , RACB , MGNX , MRTX , TPTX , ARVN , IOVA , ATRA ,
   Algert Coldiron Investors Llc Buys Herbalife Nutrition, Carter''s Inc, Tandem Diabetes Care Inc, ...  2021/08/16 23:38:16 GuruFocus
Related Stocks: HLF , TNDM , AMZN , UNVR , SLGN , TNET , CRI , BA , EQIX , CPRT , GOOG , ANTM , WFC , V , INTC , VLO , ROST , BWXT ,
   The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax  2020/09/03 11:55:02 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Avid Bioservices Inc (NASDAQ: CDMO ) ( reacted to strong quarterly results) BioLife Solutions Inc (NASDAQ: BLFS ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) Edwards Lifesciences Corp (NYSE: EW ) Evogene Ltd (NASDAQ: EVGN ) Fortress Biotech (NASDAQ: FBIO ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) (priced its 5.27-million-share common stock offering at $33 per share) Inspire Medical Systems Inc (NYSE: INSP ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Silk Road Medical Inc (NASDAQ: SILK ) Shockwave Medical Inc (NASDAQ: SWAV ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) (announced potent SARS-CoV-2 neutralizing data from COVID-19 therapeutic antibody program) West Pharmaceutical Services Inc. (NYSE: WST ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 2) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADiTx Therapeutics Inc (NASDAQ: ADTX ) (priced a $9.6-million follow-on offering) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC ) Entera Bio Ltd (NASDAQ: ENTX ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Gritstone Oncology Inc (NASDAQ: GRTS ) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Histogen Inc (NASDAQ: HSTO ) Interpace Biosciences Inc (NASDAQ: IDXG ) Iterum Therapeutics PLC (NASDAQ: ITRM ) NanoVibronix Inc (NASDAQ: NAOV ) Neurobo Pharmaceuticals Inc (NASDAQ: NRBO ) Nkarta Inc (NASDAQ: NKTX ) Oncternal Therapeutics Inc (NASDAQ: ONCT ) Psychemedics Corp. (NASDAQ: PMD ) Rockwell Medical Inc (NASDAQ: RMTI ) Sun BioPharma, Inc. (NASDAQ: SNBP ) Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS ) Stocks In Focus Sutro To Present Positive Phase 1 Ovarian Cancer Data In an abstract submitted to the International Gynecologic Cancer Society …
   Tandem Diabetes Care Announces Upcoming Webcast Conference Presentations  2020/09/02 20:05:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan, president and chief executive officer, will present a company update at the following virtual investor conferences: Wells Fargo 2020 Healthcare Conference on Wednesday, September 9, 2020 at 12:00pm Eastern Time (9:00am Pacific Time), Morgan Stanley 18th Annual Global Healthcare Conference on Wednesday, September 16, 2020 at 11:45a
   The Daily Biotech Pulse: Amarin's Vascepa Appeal Hearing, Avid Bioservices' Strong Q1, A Life Sciences Blank Check IPO  2020/09/02 11:25:11 Benzinga
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) 10X Genomics Inc (NASDAQ: TXG ) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Catalent Inc (NYSE: CTLT ) Evogene Ltd (NASDAQ: EVGN ) (announced $10 million equity investment led by ARK Investment Management) I-Mab ADR (NASDAQ: IMAB ) Immunomedics, Inc. (NASDAQ: IMMU ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Pacific Biosciences of California Inc (NASDAQ: PACB ) PPD Inc (NASDAQ: PPD ) Shockwave Medical Inc (NASDAQ: SWAV ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 1) Acasti Pharma Inc (NASDAQ: ACST ) ADiTx Therapeutics Inc (NASDAQ: ADTX ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Entera Bio Ltd (NASDAQ: ENTX ) Freeline Therapeutics Holdings PLC (NASDAQ: FRLN ) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Histogen Inc (NASDAQ: HSTO ) Immatics NV (NASDAQ: IMTX ) NanoVibronix Inc (NASDAQ: NAOV ) Oncternal Therapeutics Inc (NASDAQ: ONCT ) Predictive Oncology Inc (NASDAQ: POAI ) Rockwell Medical Inc (NASDAQ: RMTI ) Sun BioPharma, Inc. (NASDAQ: SNBP ) Stocks In Focus Mesoblast Gets Ethics Approval For Using Stem Cell Therapy In COVID-19 Patients In Australia Mesoblast (NASDAQ: MESO ) said it has received ethics approval to include Australian hospitals in the Phase 3 randomized controlled trial of remestemcel-L in ventilator-dependent COVID-19 patients with acute respiratory distress syndrome.
   Tandem Diabetes Care Announces Second Quarter 2020 Financial Results and Full Year 2020 Sales Guidance  2020/07/30 20:05:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)---- $TNDM #ControlIQ--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2020. In addition, the Company provided sales guidance for the year ending December 31, 2020. “We achieved our highest quarterly sales, successfully completed our first acquisition, and executed multiple meaningful agreements in support of our longer-term objectives in the second quarter,” said John
   Tandem Diabetes Care Appoints Peyton Howell to Board of Directors  2020/07/29 20:05:00 Business Wire
SAN DIEGO--(BUSINESS WIRE)---- $TNDM--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Peyton Howell as an independent member of its board of directors effective August 3, 2020. Ms. Howell brings to the Tandem board extensive reimbursement, health insurance, and patient access experience across a broad range of disease states in the hospital, physician, pharmacy and home care settings. “Peyton brings significant expe

calendar